Remogliflozin Etabonate 100 mg + Metformin 500 mg Tablet – Manufacturer, Supplier & PCD Franchise
Remogliflozin Etabonate 100 mg + Metformin 500 mg Tablet
Remogliflozin Etabonate 100 mg + Metformin 500 mg — PCD Pharma Franchise, Wholesale Supply & Third Party Manufacturing
Form: Tablet
Class: Fixed-Dose Combination — SGLT2 inhibitor + Biguanide antidiabetic
✓ Pan-India Monopoly PCD
✓ Available Now
Pricing, brochure & monopoly territory within 24 hrs.
Remogliflozin Etabonate 100 mg + Metformin 500 mg Tablet is manufactured and supplied by Trumac Healthcare, a WHO-GMP certified pharmaceutical company in India. This tablet is available for monopoly PCD pharma franchise, wholesale and distributor supply, and third party / contract manufacturing across all Indian states.
Therapeutic Indications
- Type 2 diabetes mellitus, alone or with metformin
- Adjunct to diet and exercise for glycaemic control
- Combination therapy with other oral antidiabetic agents
Mechanism of Action
Remogliflozin Etabonate — A prodrug converted to remogliflozin, which blocks renal SGLT2, reducing glucose reabsorption and increasing glucose excretion in urine to lower blood sugar.
Metformin — Reduces glucose production by the liver and improves insulin sensitivity in muscle, lowering blood sugar without stimulating insulin release.
Combining these ingredients in one tablet provides complementary action on the target condition and simplifies therapy compared with taking the components separately.
Dosage & Administration
- Dosage of Remogliflozin Etabonate 100 mg + Metformin 500 mg Tablet must be individualised by the treating physician according to the patient's age, body weight, indication, disease severity and renal or hepatic function.
- Refer to the approved prescribing information for exact dose, frequency, route and duration of therapy.
- Do not exceed the prescribed dose, and complete the full course as advised.
- Dose adjustment may be required in renal or hepatic impairment, in the elderly and in paediatric patients.
- To be dispensed only against a valid prescription from a registered medical practitioner.
Side Effects
- Genital fungal infections
- Urinary tract infections
- Increased urination
- Nausea and stomach upset
- Diarrhoea
- Metallic taste
Contraindications
- Known hypersensitivity to any component of the formulation
- Type 1 diabetes or diabetic ketoacidosis
- Severe renal impairment
- Severe kidney impairment
- Conditions causing low oxygen, e.g. heart failure, severe infection
Storage
Store below 30 °C in a dry place, protected from light and moisture. Keep in the original packaging until use. Keep out of reach of children. Dispense strictly on a registered medical practitioner's prescription.
Offered by Trumac Healthcare, a PCD pharma franchise company, available on a monopoly basis – see the cardiac diabetic pharma franchise product list (PDF). See our full tablet range for PCD franchise. Comparing companies? See the top cardiac-diabetic PCD companies compared. No franchise fee; minimum first order ₹25,000 – cost and documents.
Schedule G: Metformin is listed in Schedule G of the Drugs Rules, 1945, so the pack carries the red-box caution “SCHEDULE G PRESCRIPTION DRUG – CAUTION: It is dangerous to take this preparation except under medical supervision”. Combinations that also contain a Schedule H molecule carry the Rx label too. See the Schedule G drugs list.
See the full antidiabetic tablets range – manufacturer, supplier and PCD franchise: SGLT2 and DPP-4 inhibitors, glimepiride, gliclazide, metformin, voglibose and their combinations.
PCD Pharma Franchise & Third Party Manufacturing — Remogliflozin Etabonate + Metformin Tablet
- ✓ Made at WHO-GMP certified partner units — every batch QC released
- ✓ Monopoly PCD franchise rights at district or state level
- ✓ Third party / contract manufacturing under your own brand
- ✓ Wholesale and distributor supply against drug licence + GST
- ✓ Attractive net rates with healthy PTR / PTS margins
- ✓ Dispatch within 48 hours of payment realisation
Composition: Remogliflozin Etabonate 100 mg + Metformin 500 mg. It is a fixed-dose combination of SGLT2 inhibitor and biguanide antidiabetic, used for type 2 diabetes mellitus, alone or with metformin and combination therapy with other oral antidiabetic agents. Trumac Healthcare supplies it with complete quality documentation — batch Certificate of Analysis, GMP certificate and statutory invoicing — to PCD franchise partners, stockists, wholesalers and hospital supply chains nationwide.
Remogliflozin Etabonate + Metformin Tablet brings together Remogliflozin Etabonate (SGLT2 inhibitor) and Metformin (biguanide antidiabetic) in a single fixed-dose formulation.
PCD franchise partners receive monopoly territory rights at district or state level, promotional support including visual aids and sample literature, competitive net rates with healthy PTR/PTS margins, and dispatch within 48 hours of payment realisation. Third party manufacturing of Remogliflozin Etabonate + Metformin Tablet under your own brand name is available subject to minimum order quantity and valid drug licence and GST documentation.
Frequently Asked Questions
Who manufactures Remogliflozin Etabonate + Metformin Tablet in India?
Trumac Healthcare is a supplier of Remogliflozin Etabonate + Metformin Tablet in India; products are made at WHO-GMP certified partner units. We supply pan-India to PCD franchise partners, wholesalers, distributors and hospital chains, with full QC documentation and batch Certificate of Analysis. Contact +91 90416 77932 for net rates and availability.
What is Remogliflozin Etabonate + Metformin Tablet used for?
Remogliflozin Etabonate + Metformin Tablet is used for type 2 diabetes mellitus, alone or with metformin; adjunct to diet and exercise for glycaemic control; combination therapy with other oral antidiabetic agents. It should be used as advised by a registered medical practitioner.
Is Remogliflozin Etabonate + Metformin Tablet available for PCD pharma franchise on monopoly basis?
Yes. Remogliflozin Etabonate 100 mg + Metformin 500 mg Tablet is available for monopoly PCD (Propaganda Cum Distribution) pharma franchise across India, with monopoly rights granted at district or state level. Franchise partners receive promotional support, territory protection, competitive net rates with healthy PTR/PTS margins and dedicated backend support.
Do you offer Remogliflozin Etabonate + Metformin for third party or contract manufacturing?
Yes. Trumac Healthcare undertakes third party manufacturing and contract manufacturing of Remogliflozin Etabonate + Metformin Tablet under your own brand name, subject to minimum order quantity and valid drug licence and GST documentation. Custom pack sizes, carton design and artwork are supported.
Can Remogliflozin Etabonate + Metformin Tablet be supplied on wholesale or distributor basis?
Yes. Beyond PCD franchise, this product is supplied to wholesalers, stockists and distributors at wholesale rates against a valid drug licence and GST registration. Bulk and institutional supply is available on request.
What is the therapeutic class of Remogliflozin Etabonate + Metformin?
Remogliflozin Etabonate + Metformin is a fixed-dose combination of SGLT2 inhibitor and biguanide antidiabetic (therapeutic class: Fixed-Dose Combination — SGLT2 inhibitor + Biguanide antidiabetic).
What documentation is provided with each supply?
Every batch ships with a Certificate of Analysis (COA), GMP certificate, drug licence copies and statutory invoice. We also support PCD partner documentation including monopoly agreement, rate contract and product list.
How quickly can an order be dispatched?
Routine PCD orders are dispatched within 48 hours of payment realisation, subject to stock availability and your distance from our depot. For monopoly partners we maintain buffer stock against forecasted monthly off-take.
Is a prescription required for Remogliflozin Etabonate + Metformin Tablet?
Yes. This is a prescription medicine and must be used strictly under the supervision of a registered medical practitioner. PCD franchise distribution is through licensed retail pharmacies and hospital supply chains only.
Ready to start your PCD franchise for Remogliflozin Etabonate 100 mg + Metformin 500 mg Tablet?
